Vitamin D3 and Colorectal Cancer

  • M. J. Larriba
  • N. Valle
  • S. Álvarez
  • A. Muñoz
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 617)

Vitamin D3 intake and sunlight exposure have a protective effect against colorectal cancer (CRC) and other neoplasias. In line with epidemiological data, the most active metabolite of vitamin D3,1α, 25-dihydroxyvitamin D3, [1α,25(OH)2D3] has antiproliferative, prodifferentiation and proapoptotic effects on cultured human colon cancer cells and antitumoral action in colon cancer mouse models. Intense research is ongoing to identify 1α,25(OH)2D3 target genes and the mechanisms responsible for its antitumoral actions, as well as to define treatments based on 1α,25(OH)2D3 analogs for clinical use. However, colon cancer cells can develop resistance to 1α,25(OH)2D3 action due to aberrant expression of the enzymes responsible for its synthesis and catabolism or to the down-regulation of vitamin D receptor, a ligand-regulated transcription factor that mediates most 1α,25(OH)2D3 actions.


Colon Cancer Cell Human Colon Cancer Cell Colon Cancer Progression Epidermal Growth Factor Pathway SNAIL1 Overexpression 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Sancho E, Batlle E, Clevers H (2004) Signaling pathways in intestinal development and cancer. Annu Rev Cell Dev Biol 20:695–723.PubMedCrossRefGoogle Scholar
  2. 2.
    Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759–767.PubMedCrossRefGoogle Scholar
  3. 3.
    Gregorieff A, Clevers H (2005) Wnt signaling in the intestinal epithelium: from endoderm to cancer. Genes Dev 19:877–890.PubMedCrossRefGoogle Scholar
  4. 4.
    Sutton ALM, MacDonald PN (2003) Vitamin D: more than a “bone-a-fide” hormone. Mol Endocrinol 17:777–791.PubMedCrossRefGoogle Scholar
  5. 5.
    Ordóñez-Morán P, Larriba MJ, Pendás-Franco N, et al. (2005) Vitamin D and cancer: an update of in vitro and in vivo data. Front Biosci 10:2723–2749.PubMedCrossRefGoogle Scholar
  6. 6.
    Garland CF, Garland FC, Gorham ED, et al (2006) The role of vitamin D in cancer prevention. Am J Public Health 96:252–261.PubMedCrossRefGoogle Scholar
  7. 7.
    Huerta S, Irwin RW, Heber D, et al. (2002) 1α, 25-(OH)2D3 and its synthetic analogue decrease tumor load in the Apcmin mouse. Cancer Res 62:741–746.PubMedGoogle Scholar
  8. 8.
    Pálmer HG, Larriba MJ, García JM, et al. (2004) The transcription factor SNAIL represses vitamin D receptor expression and responsiveness in human colon cancer. Nat Med 10:917–919.PubMedCrossRefGoogle Scholar
  9. 9.
    Saramaki A, Banwell CM, Campbell MJ, et al. (2006) Regulation of the human p21 (waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor. Nucleic Acids Res 34:543–554.PubMedCrossRefGoogle Scholar
  10. 10.
    Lin R, Wang TT, Miller WH, et al (2003) Inhibition of F-Box protein p45SKP2 expression and stabilization of cyclin-dependent kinase inhibitor p27KIP1 in vitamin D analog-treated cancer cells. Endocrinology 144:749–753.PubMedCrossRefGoogle Scholar
  11. 11.
    Cheng HT, Chen JY, Huang YC, et al. (2006) Functional role of VDR in the activation of p27Kip1 by the VDR/Sp1 complex. J Cell Biochem 98(6):1450–1456.PubMedCrossRefGoogle Scholar
  12. 12.
    Fernández-García NI, Pálmer HG, García M, et al (2005) 1α,25-Dihydroxyvitamin D3 regulates the expression of Id1 and Id2 genes and the angiogenic phenotype of human colon carcinoma cells. Oncogene 24:6533–6544.PubMedGoogle Scholar
  13. 13.
    Tong W-M, Hofer H, Ellinger A, et al. (1999) Mechanism of antimitogenic action of vitamin D in human colon carcinoma cells: relevance for suppression of epidermal growth factor-stimulated cell growth. Oncol Res 11:77–84.PubMedGoogle Scholar
  14. 14.
    González-Sancho JM, Larriba MJ, Ordónez-Morán P, et al (2006) Effects of 1α,25-dihydroxyvitamin D3 in human colon cancer cells. Anticancer Res 26:2669–2682.PubMedGoogle Scholar
  15. 15.
    Oh YS, Kim EJ, Schaffer BS, et al. (2001) Synthetic low-calcaemic vitamin D3 analogues inhibit secretion of insulin-like growth factor II and stimulate production of insulin-like growth factor-binding protein-6 in conjunction with growth suppression of HT-29 colon cancer cells. Mol Cell Endocrinol 183:141–149.PubMedCrossRefGoogle Scholar
  16. 16.
    Chen A, Davis BH, Sitrin MD, et al. (2002) Transforming growth factor-β 1 signaling contributes to Caco-2 cell growth inhibition induced by 1,25(OH)2D3. Am J Physiol Gastrointest Liver Physiol 283:G864–G874.PubMedGoogle Scholar
  17. 17.
    Yanagisawa J, Yanagi Y, Masuhiro Y, et al. (1999) Convergence of transforming growth factor-β and vitamin D signaling pathways on SMAD transcriptional coactivators. Science 283:1317–1321.PubMedCrossRefGoogle Scholar
  18. 18.
    Pálmer HG, González-Sancho JM, Espada J, et al. (2001) Vitamin D3 promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of β-catenin signaling. J Cell Biol 154:369–387.PubMedCrossRefGoogle Scholar
  19. 19.
    Díaz GD, Paraskeva C, Thomas MG, et al. (2000) Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy. Cancer Res 60:2304–2312.PubMedGoogle Scholar
  20. 20.
    Pálmer HG, Sánchez-Carbayo M, Ordóñez-Morán P, et al. (2003) Genetic signatures of differentiation induced by 1α,25-dihydroxyvitamin D3 in human colon cancer cells. Cancer Res 63:7799–7806.PubMedGoogle Scholar
  21. 21.
    Makishima M, Lu TT, Xie W, et al. (2002) Vitamin D receptor as an intestinal bile acid sensor. Science 296:1313–1316.PubMedCrossRefGoogle Scholar
  22. 22.
    Banwell CM, MacCartney DP, Guy M, et al. (2006) Altered nuclear receptor corepressor expression attenuates vitamin D receptor signaling in breast cancer cells. Clin Cancer Res 12:2004–2013.PubMedCrossRefGoogle Scholar
  23. 23.
    Cross HS, Kállay E, Khorchide M, et al. (2003) Regulation of extrarenal synthesis of 1,25-dihydroxyvitamin D3-relevance for colonic cancer prevention and therapy. Mol Aspects Med 24:459–465.PubMedCrossRefGoogle Scholar
  24. 24.
    Esteban LM, Eisman JA, Gardiner EM (2005) Vitamin D receptor promoter and regulation of receptor expression. In: Feldman D, Pike JW, Glorieux FH (eds.). Vitamin D. Burlington: Elsevier Academic Press, pp. 1571–1597.Google Scholar
  25. 25.
    Barrallo-Gimeno A, Nieto MA (2005) The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development 132:3151–3161.PubMedCrossRefGoogle Scholar
  26. 26.
    Peña C, García JM, Silva J, et al. (2005) E-cadherin and vitamin D receptor regulation by SNAIL and ZEB1 in colon cancer: clinicopathological correlations. Hum Mol Genet 14:3361–3370.PubMedCrossRefGoogle Scholar
  27. 27.
    Larriba MJ, Muñoz A (2005) SNAIL vs vitamin D receptor expression in colon cancer: therapeutics implications. Br J Cancer 92:985–989.PubMedCrossRefGoogle Scholar
  28. 28.
    Kommagani R, Caserta TM, Kadakia MP (2006) Identification of vitamin D receptor as a target of p63. Oncogene 25:3745–3751.PubMedCrossRefGoogle Scholar
  29. 29.
    Maruyama R, Aoki F, Toyota M, et al. (2006) Comparative genome analysis identifies the vitamin D receptor gene as a direct target of p53-mediated transcriptional activation. Cancer Res 66:4574–4583.PubMedCrossRefGoogle Scholar
  30. 30.
    Lechner D, Kállay E, Cross HS (2005) Phytoestrogens and colorectal cancer prevention. Vitam Horm 70:169–198.PubMedCrossRefGoogle Scholar
  31. 31.
    Gaschott T, Stein J (2003) Short-chain fatty acids and colon cancer cells: the vitamin D receptor-butyrate connection. Recent Results Cancer Res 164:247–257.PubMedGoogle Scholar
  32. 32.
    Schuster I, Egger H, Reddy GS, et al. (2003) Combination of vitamin D metabolites with selective inhibitors of vitamin D metabolism. Recent Results Cancer Res 164:169–188.PubMedGoogle Scholar

Copyright information

© Springer 2008

Authors and Affiliations

  • M. J. Larriba
  • N. Valle
    • 1
  • S. Álvarez
    • 1
  • A. Muñoz
  1. 1.Instituto de Investigaciones BiomedicasMadridSpain

Personalised recommendations